The Lab of the Future: Barriers to Digital Transformation in the Life Sciences Industry
Experts predict over the next two years, life sciences companies will invest over $3 billion in AI, with two-thirds adopting the "intelligent lab of the future" within four years.
Taking a digital-first approach has become a strategic imperative in the pharmaceutical and biopharma industries. Yet many life sciences companies, big and small, are early in their digital transformation journeys or not yet gleaning value from their existing investments.
Enthought has been digitally transforming R&D for leading, global science-driven companies for over 20 years. We're providing this eBook to help guide your lab's transformation initiatives.
Download “The Lab of the Future: Five Barriers to Digital Transformation in the Life Sciences Industry” to learn:
- How current industry-specific market trends and pressures are impacting decisions
- The common barriers to successful digital transformation in life sciences
- Recommendations on what can be done now to attain the future-proofed R&D lab
Questions? Contact info@enthought.com to discuss how the Enthought Materials Science and Chemistry Solutions Group can help future-proof your R&D lab and accelerate your business.
Download eBook
Related Content
Reshaping Materials R&D: Navigating Margin Pressure in the Specialty Chemicals Industry
The era of the AI Co-Scientist is here. How is your organization preparing?
The Emergence of the AI Co-Scientist
The era of the AI Co-Scientist is here. How is your organization preparing?
Understanding Surrogate Models in Scientific R&D
Surrogate models are reshaping R&D by making research faster, more cost-effective, and more sustainable.
R&D Innovation in 2025
As we step into 2025, R&D organizations are bracing for another year of rapid-pace, transformative shifts.
Revolutionizing Materials R&D with “AI Supermodels”
Learn how AI Supermodels are allowing for faster, more accurate predictions with far fewer data points.
What to Look for in a Technology Partner for R&D
In today’s competitive R&D landscape, selecting the right technology partner is one of the most critical decisions your organization can make.
Digital Transformation vs. Digital Enhancement: A Starting Decision Framework for Technology Initiatives in R&D
Leveraging advanced technology like generative AI through digital transformation (not digital enhancement) is how to get the biggest returns in scientific R&D.
Digital Transformation in Practice
There is much more to digital transformation than technology, and a holistic strategy is crucial for the journey.
Leveraging AI for More Efficient Research in BioPharma
In the rapidly-evolving landscape of drug discovery and development, traditional approaches to R&D in biopharma are no longer sufficient. Artificial intelligence (AI) continues to be a...
Utilizing LLMs Today in Industrial Materials and Chemical R&D
Leveraging large language models (LLMs) in materials science and chemical R&D isn't just a speculative venture for some AI future. There are two primary use...